Dr Catherine Marie Depalma, MD in Evanston, WY - Pediatrics

Dr Catherine Marie Depalma, MD is a Pediatrics physician based in Evanston, Wyoming. Dr Catherine Marie Depalma is licensed to practice in Wyoming (license number 7258A) and her current practice location is 195 Feather Way, Evanston, Wyoming. She can be reached at her office (for appointments etc.) via phone at (307) 789-1102.

NPI number for Dr Catherine Marie Depalma is 1144272394 and her current mailing address is 195 Feather Way, Evanston, Wyoming. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1144272394.

Contact Information

	Dr Catherine Marie Depalma, MD
	195 Feather Way, Evanston, WY 82930-9227
	(307) 789-1102
	(307) 789-9273

Physician's Profile

Full Name	Dr Catherine Marie Depalma
Gender	Female
Speciality	Pediatrics
Location	195 Feather Way, Evanston, Wyoming
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1144272394
Provider Enumeration Date: 05/16/2006
Last Update Date: 05/19/2022

Medical Identifiers

Medical identifiers for Dr Catherine Marie Depalma such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1144272394	NPI	-	NPPES
121468300	Medicaid	WY

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	7258A (Wyoming)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Catherine Marie Depalma is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Catherine Marie Depalma, MD 195 Feather Way, Evanston, WY 82930-9227 Ph: (307) 789-1102	Dr Catherine Marie Depalma, MD 195 Feather Way, Evanston, WY 82930-9227 Ph: (307) 789-1102

News Archive

Bioniche reduces net loss per share from $0.15 in fiscal 2009 to $0.02 in fiscal 2010

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its 2010 fiscal year ended June 30, 2010.

Canadian-Israeli researchers develop new biological pacemaker

Using human embryonic stem cells to create a type of cardiac cells known as sinotrial (SA) node pacemaker cells, a team of scientists from Israel and Canada have developed a biological pacemaker that overcomes many of the limitations of electrical pacemakers.

Research on alpha-synuclein protein could lead to new therapies for Parkinson's disease

A protein known to be a key player in the development of Parkinson's disease is able to enter and harm cells in the same way that viruses do, according to a Loyola University Chicago Stritch School of Medicine study.

Bavarian Nordic completes last step to support use of IMVAMUNE, receives FDA notification

Bavarian Nordic A/S announced today that it has received notification that the U.S. Food and Drug Administration (FDA) has accepted all the actions taken by the company to address the observations made during the inspection of the manufacturing facilities in 2009. This was the last step along with the clinical and preclinical data that will be used to potentially support the use of IMVAMUNE® following a declared emergency.

Dr Catherine Marie Depalma, MD - Pediatrics in Evanston, WY